1. Olsen EA: Disorders of Hair Growth, vol. 1, 2nd edition, New York, McGraw-Hill Companies, 2003
2. Trüeb R: Haare – Praxis der Trichologie, vol. 1, 1st edition. Darmstadt, Steinkopff, 2003
3. Stenn KS, Paus R, Filippi M: Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol 110:95, 1998
4. Pinkus H: “Sebaceous cysts” are trichilemmal cysts. Arch Dermatol 99:544-555, 1969
5. Cotsarelis G, Sun TT, Lavker RM: Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61:1329-1337, 1990
6. Paus R: Therapeutic strategies for treating hair loss. Drug Dis Today Ther Strat 3:101, 2006
7. Arck PC et al: Neuroimmunology of stress: Skin takes center stage. J Invest Dermatol 126:1697, 2006
8. Botchkarev
VA: Molecular mechanisms of chemotherapy-induced hair loss.
J Investig Dermatol Symp Proc 8:72, 2003
9. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 341:491, 1999
10. Stenn K, Paus R: Controls of hair follicle cycling. Physiol Rev 81:449, 2001
11. Nordlund JJ et al: The Pigmentary System: Physiology and Pathophysiology. NewYork, Oxford University Press, 1998
12. Rees JL: Genetics of hair and skin color. Annu Rev Genet 37:67-90, 2003. Review
13. Tobin DJ: The biogenesis and growth of human hair. In: Hair in Toxicology—An Important Bio-Monitor, vol. 1, edited by T DJ. Cambridge, RSCPublishing, 2005
14. Tobin DJ. Pigmentation of human hair. In: Hair in Toxicology—An Important Bio-Monitor, vol. 1, T DJ. Cambridge, RSCPublishing, 2005
15. Wakamatsu K, Ito S: Advanced chemical methods in melanin determination. Pigment Cell Res 15:174-183, 2002
16. Tobin DJ, Hordinsky M, Bernard BA: Hair pigmentation: A research update. J Investig Dermatol Symp Proc 10:275-279, 2005
17. Whiting DA: Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 28:755-763, 1993
18. Sperling LC: Hair density in African Americans. Arch Dermatol 135:656-658, 1999
19. Jackson JP Jr: “In Ways Unacademical”: The Reception of Carleton S. Coon's The Origin of Races. JHistBiol 34:247-285, 2001
20. Shapiro J: Hair Loss: Principles of Diagnosis and Management of Alopecia. London, Martin Dunitz, 2002
21. Loussouarn G: African hair growth parameters. Br J Dermatol 145:294-297, 2001
22. Loussouarn G et al: Worldwide diversity of hair curliness: A new method of assessment. Int J Dermatol 46:2-6, 2007
23. Porter CE et al: The influence of African-American hair's curl pattern on its mechanical properties. Int J Dermatol 44:4-5, 2005
24. De la Mettrie R et al: Shape variability and classification of human hair: A worldwide approach. Hum Biol 79:265-281, 2007
25. Hadshiew I et al: Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 123:455-457, 2004
26. Hunt N, McHale S: The psychological impact of alopecia. BMJ 331:951, 2005
27. Olsen EA et al: Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center. J Am Acad Dermatol 48:103-110, 2003
28. Hillmann K, Blume-Peytavi U: Diagnosis of hair disorders. Semin Cutan Med Surg 28:33-38, 2009
29. Bouhanna P: Current treatment of androgenetic male and female alopecia (with the exception of hormone treatment). Praxis (Bern 1994). 86:996-999, 1997
30. D'Amico D et al: Phototrichogram using videomicroscopy: A useful technique in the evaluation of scalp hair. Eur J Dermatol 11:17-20, 2001
31. Ekmekci TR, Koslu A: Phototrichogram findings in women with androgenetic alopecia. Skin Res Technol 12:309-312, 2006
32. Van Neste D, Trüeb RM: Critical study of hair growth analysis with computer-assisted methods. J Eur Acad Dermatol Venereol 20:578-583, 2006
33. Ross EK, Vincenzi C, Tosti A: Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 55:799-806, 2006
34. Tosti A, Gray J: Assessment of hair and scalp disorders. J Investig Dermatol Symp Proc 12:23-27, 2007
35. Birch MP et al: Female pattern hair loss, sebum excretion and the end-organ response to androgens. Br J Dermatol 154:85-89, 2006
36. Birch MP, Messenger JF, Messenger AG: Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297, 2001
37. Courtois M et al: Hair cycle and alopecia. Skin Pharmacol 7:84-89, 1994
38. Ellis JA, Sinclair R, Harrap SB: Androgenetic alopecia: Pathogenesis and potential for therapy. Expert RevMol Med 4:1-11, 2004
39. Camacho FM, Randall
VA, Price VH:
Hair and its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000.
40. Rushton DH et al: Natural progression of male pattern baldness in young men. Clin Exp Dermatol 16:188-192, 1991
41. Olsen EA, DeLong ER, Weiner MS: Long-term follow-up of men with male pattern baldness treated with topical
minoxidil.
J Am Acad Dermatol 16:688-695, 1987
42. Chumlea WC et al: Family history and risk of hair loss. Dermatology 209:33-39, 2004
43. Otberg N, Finner AM, Shapiro J: Androgenetic alopecia. Endocrinol Metab Clin North Am 36:379-398, 2007
44. Setty LR: Hair patterns of scalp of white and Negro males. Am J Phys Anthropol 33:49-55, 1970
45. Paik JH et al: The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 145:95-99, 2001
46. Pathomvanich D et al: A random study of Asian male androgenetic alopecia in Bangkok, Thailand. Dermatol Surg 28:9, 2002
47. Takashima I, Iju M, Sudo M: Alopecia androgenetica: Its incidence in Japanese and associated conditions. Hair Research: Status and Future Aspects. New York, Springer-Verlag 1981, pp. 287-293
48. Norwood OT: Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 27:53, 2001
49. Camacho F, Camacho F, Montagna W: Trichology: Diseases of the Pilosebaceus Follicle. Madrid, Aula Medica, 1997, p. 80
50. Hamilton JB: Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 71:451-480, 1942
51. Severi G et al: Epidemiology and Health Services Research Androgenetic alopecia in men aged 40-69 years: Prevalence and risk factors. Br J Dermatol 149:1207-1213, 2003
52. Simpson NB, Barth JH: Hair patterns: Hirsuties and androgenetic alopecia. In: The Diseases of the Hair and Scalp, edited by A Rook, R Dawber. Oxford, England, Blackwell Science, 1997, pp. 95-101
53. Grino PB, Griffin JE, Wilson JD:
Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone.
Endocrinology 126:1165-1172, 1990
54. Thigpen AE et al: Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92:903-910, 1993
55. Sawaya ME, Price VH: Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109:296-300, 1997
56. Schweikert HU, Wilson JD: Regulation of human hair growth by steroid hormones. II. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab 39:1012-1019, 1974
57. Imperato-McGinley J: 5alpha-reductase-2 deficiency and complete androgen insensitivity: Lessons from nature. Adv Exp Med Biol 511:121-131, 2002; discussion 31-34, 2002
58. Imperato-McGinley J et al: Steroid 5alpha-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science 186:1213-1215, 1974
59. Drake L et al: The effects of
finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
J Am Acad Dermatol 41:550-554, 1999
60. Randall
VA, Thornton MJ, Messenger AG: Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of scalp.
J Endocrinol 133:141-147, 1992
61. Hatch R et al: Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol 140:815-830, 1981
62. Zouboulis CC et al: Sexual hormones in human skin. Horm Metab Res 39:85-95, 2007
63. Vexiau P et al: Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res 292:598-604, 2000
64. Kasick JM et al: Adrenal androgenic female-pattern alopecia: Sex hormones and the balding woman. Cleve Clin Q 50:111-122, 1983
65. Miller JA et al: Low sex-hormone binding globulin levels in young women with diffuse hair loss. Br J Dermatol 106:331-336, 1982
66. Futterweit W et al: The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 19:831-836, 1988
67. Giagulli
VA et al: Precursors of plasma androstanediol- and androgen-glucuronides in women.
J Steroid Biochem 33:935-940, 1989
68. Vermeulen A et al: Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans. Prostate 14:45-53, 1989
69. Shum KW, Cullen DR, Messenger AG: Hair loss in women with hyperandrogenism: Four cases responding to
finasteride.
J Am Acad Dermatol 47:733-739, 2002
70. Chumlea WC et al: Family history and risk of hair loss. Dermatology 209:33-39, 2004
71. Hayakawa K et al: Intrapair differences of physical aging and longevity in identical twins. Acta Genet Med Gemellol (Roma) 41:177-185, 1998
72. Nyholt DR et al: Genetic basis of male pattern baldness. J Invest Dermatol 121:1561-1564, 2003
73. Osborn D: Inheritance of baldness. J Hered 7:347-355, 1916
74. Carey AH et al: Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38:653-658, 1993
75. Waterworth DM et al: Linkage and association of
insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
Lancet 349:986-990, 1997
76. Ellis JA, Stebbing M, Harrap SB: Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 110:849-853, 1998
77. Küster W, Happle R. The inheritance of common baldness: Two B or not two B? J Am Acad Dermatol 11:921-926, 1984
78. Garton RA et al: Association of a polymorphism in the ornithine decarboxylase gene with male androgenetic alopecia. J Am Acad Dermatol 52:535-536, 2005
79. Ellis JA, Stebbing M, Harrap SB: Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452-455, 2001
80. König A et al: An X-linked gene involved in androgenetic alopecia: A lesson to be learned from adrenoleukodystrophy. Dermatology 200:213-218, 2000
81. Hibberts NA, Howell AE, Randall
VA: Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp.
J Endocrinol 156:59-65, 1998
82. Hayes VM et al: The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 14:993-996, 2005
83. Chang CS, Kokontis J, Liao ST: Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A 85:7211-7215, 1988
84. Levy-Nissenbaum E et al: Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin. Nat Genet 34:151-153, 2003
85. Ellis JA et al: Baldness and the androgen receptor: The AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 121:451-457, 2007
86. Richards JB et al: Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40:1282-1284, 2008
87. Antaya RJ, Sideridou E, Olsen EA: Short anagen syndrome. J Am Acad Dermatol 53:S130, 2005
88. Barman JM, Pecoraro V, Astore I: Biological basis of the inception and evolution of baldness. J Gerontol 24:163-168, 1969
89. Yazdabadi A et al: The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit. Br J Dermatol 159:1300-1302, 2008
90. Hamilton JB: Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53:708-728, 1951
91. Rook A, Wilkinson DS, Ebling FJG: Textbook of Dermatology, 2nd edition. Oxford, Blackwell Scientific, 1972
92. Ludwig E: Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247-254, 1977
93. Herrera CR et al: Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 142:828-833, 1995
94. Lotufo PA et al: Male Pattern Baldness and Coronary Heart Disease The Physicians' Health Study. In: American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use, 2000
95. Matilainen
VA, Makinen PK, Keinanen-Kiukaanniemi SM: Early onset of androgenetic alopecia associated with early severe coronary heart disease: A population-based, case-control study.
J Cardiovasc Risk 8:147-151, 2001
96. Hawk E, Breslow RA, Graubard BI: Male Pattern Baldness and Clinical Prostate Cancer in the Epidemiologic Follow-Up of the First National Health and Nutrition Examination Survey. In 2000
97. Giles GG et al: Androgenetic alopecia and prostate cancer: Findings from an Australian case-control study 1. Cancer Epidemiol Biomarkers Prev 11:549-553, 2002
98. Buhl AE et al:
Minoxidil sulfate is the active metabolite that stimulates hair follicles.
J Invest Dermatol 95:553-557, 1990
99. Buhl AE et al:
Minoxidil stimulates mouse vibrissae follicles in organ culture.
J Invest Dermatol 92:315-320, 1989
100. Cohen RL et al: Direct effects of
minoxidil on epidermal cells in culture.
J Invest Dermatol 82:90-93, 1984
101. Buhl AE et al: Potassium channel conductance: A mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol 98:315-319, 1992
102. Shapiro J, Price VH: Hair regrowth. Therapeutic agents. Dermatol Clin 16:341-356, 1998
103. Roberts JL et al: Clinical dose ranging studies with
finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
J Am Acad Dermatol 41:555-563, 1999
104. Leyden J et al:
Finasteride in the treatment of men with frontal male pattern hair loss.
J Am Acad Dermatol 40:930-937, 1999
105. McClellan KJ, Markham A:
Finasteride: A review of its use in male pattern hair loss.
Drugs 57:111-126, 1999
106. Bolduc C, Shapiro J: Management of androgenetic alopecia. Am J Clin Dermatol 1:151-158, 2000
107. Trial RC: Efficacy and tolerability of
finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
Eur J Dermatol 13:150-160, 2003
108. Kaufman KD et al:
Finasteride in the treatment of men with androgenetic alopecia.
Finasteride Male Pattern Hair Loss Study Group.
J Am Acad Dermatol 39:578-589, 1998
109. Price VH: Treatment of hair loss. N Engl J Med 341:964-973, 1999
110. Overstreet JW et al: Chronic treatment with
finasteride daily does not affect spermatogenesis or semen production in young men.
J Urol 162:1295-1300, 1999
111. Pannek J et al: Influence of
finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia.
J Urol 159:449-453, 1998
112. Alsantali A, Shapiro J: Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes 16:246-253, 2009
113. Avram M, Rogers N: Contemporary hair transplantation. Dermatol Surg 35:1705-1719, 2009
114. Rathnayake D, Sinclair R: Male androgenetic alopecia. Expert Opin Pharmacother 11:1295-1304, 2010
115. Rogers NE, Avram MR: Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 59:547-566, 2008
116. Reismann P et al: Pharmacological options for treatment of hyperandrogenic disorders. Mini Rev Med Chem 9:1113-1126, 2009
117. Karrer-Voegeli S et al: Androgen dependence of hirsutism, acne, and alopecia in women: Retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore) 88:32-45, 2009
118. Camacho-Martínez FM: Hair loss in women. Semin Cutan Med Surg 28:19-32, 2009
119. Hoffmann R et al: 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol 11:376-380, 2002
120. Niiyama S, Happle R, Hoffmann R: Influence of
estrogens on the androgen metabolism in different subunits of human hair follicles.
Eur J Dermatol 11:195-198, 2001
121. Ohnemus U et al: The hair follicle as an estrogen target and source. Endocr Rev 27:677-706, 2006
122. Avram MR et al: The current role of laser/light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 9:27-28, 2007
123. Avram MR, Rogers NE: The use of low-level light for hair growth: Part I. J Cosmet Laser Ther 11:110-117, 2009
124. Leavitt M et al: HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig 29:283-292, 2009
125. Bernstein RM, Rassman WR, Stough D: In support of follicular unit transplantation. Dermatol Surg 26:160-162, 2000
126. Stough D, Whitworth JM: Methodology of follicular unit hair transplantation. Dermatol Clin 17:297-306, 1999
127. Davalos NO et al: A non-sense mutation in the corneodesmosin gene in a Mexican family with hypotrichosis simplex of the scalp. Br J Dermatol 153:1216-1219, 2005
128. Naeem M, Jelani M, Lee K et al: Ectodermal dysplasia of hair and nail type: Mapping of a novel locus to chromosome 17p12-q21.2. Br J Dermatol 155:1184-1190, 2006
129. Cui CY et al: Ectodysplasin regulates the lymphotoxin-beta pathway for hair differentiation. Proc Natl Acad Sci USA 103:9142-9147, 2006
130. Millar SE: An ideal society? Neighbors of diverse origins interact to create and maintain complex mini-organs in the skin. PLoS Bio 3:e372, 2005
131. Schmidt-Ullrich R, Paus R: Molecular principles of hair follicle induction and morphogenesis. Bioessays 27:247, 2005
132. Damste TJ, Prakken JR: Atrichia with papular lesions: Variant of congenital ectodermal dysplasia. Dermatologica 108:114, 1954
133. Occella C et al: Noonan syndrome and keratosis pilaris atrophicans faciei. Significance of dermatologic changes. Minerva Pediatr 37:181-186, 1985
134. Sadick NS: Clinical and laboratory evaluation of AIDS trichopathy. Int J Dermatol 32:33-38, 1993
135. Kligman AM: Pathologic dynamics of human hair loss. I. Telogen effuvium. Arch Dermatol 83:175-198, 1961
136. Headington JT: Telogen effluvium. New concepts and review. Arch Dermatol 129:356-363, 1993
137. Lynfield YL: Effect of pregnancy on the human hair cycle. J Invest Dermatol 35:323-327, 1960
138. Conde J et al: A case of imiquimod-induced alopecia. J Dermatolog Treat 1:1-3, 2009
139. Graeber CW, Lapkin RA:
Metoprolol and alopecia.
Cutis 28:633-634, 1981
140. Hilder RJ.
Propranolol and alopecia.
Cutis 24:63-64, 1979
141. Leaker B, Whitworth JA: Alopecia associated with
captopril treatment.
Aust N Z J Med 14:866, 1984
142. Dawber R, Comaish S. Scanning electron microscopy of normal and abnormal hair shafts. Arch Dermatol 101:316, 1970
143. Marshall A, Williams MJ: Alopecia and
levodopa.
Br Med J 2:47, 1971
144. Holowach J, Sanden HV: Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases. N Engl J Med 263:1187, 1960
145. Blum I, Leiba S: Increased hair loss as a side effect of
bromocriptine treatment.
N Engl J Med 303:1418, 1980
146. Berth-Jones J, Shuttleworth D, Hutchinson PE: A study of etretinate alopecia. Br J Dermatol 122:751-755, 1990
147. Whiting DA: Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35:899-906, 1996
148. Alhaj E, Alhaj N, Alhaj NE: Diffuse alopecia in a child due to dietary zinc deficiency. Skinmed 6:199-200, 2007
149. Deloche C et al: Low iron stores: A risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 17:507-512, 2007
150. Trost LB, Bergfeld WF, Calogeras E: The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 54:824-844, 2006
151. Rushton DH et al: Iron and hair loss in women; what is deficiency? This is the real question! author reply 519 (Comment on: J Am Acad Dermatol 54(5):824-844, 2006). J Am Acad Dermatol 56:518-519, 2007
152. Shrivastava SB: Diffuse hair loss in an adult female: Approach to diagnosis and management. Indian J Dermatol Venereol Leprol 75:20-27, 2009
153. Shapiro J: Clinical practice. Hair loss in women. N Engl J Med 357:1620-1630, 2007
154. Price VH: Alopecia areata: Clinical aspects. J Invest Dermatol 96:68S, 1991
155. Safavi K: Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 128:702, 1992
156. Gilhar A, Kalish RS: Alopecia areata: A tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 5:64, 2006
157. Gilhar A, Paus R, Kalish R: Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 111:2019, 2007
158. McDonagh AJG, Messenger AG: The pathogenesis of alopecia areata. Dermatol Clin 14:661, 1996
159. Paus R, Nickoloff BJ, Ito T: A ‘hairy’ privilege. Trends Immunol 26:32, 2005
160. Paus R et al: A murine model for inducing and manipulating hair follicle regression (catagen): Effects of
dexamethasone and cyclosporin A.
J Invest Dermatol 103:143-147, 1994
161. Shellow WV, Edwards JE, Koo JY: Profile of alopecia areata: A questionnaire analysis of patient and family. Int J Dermatol 31:186-189, 1992
162. Price VH, Colombe BW: Heritable factors distinguish two types of alopecia areata. Dermatol Clin 14:679-689, 1996
163. Petukhova L et al: Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466(7302):113-117, 2010. PMID: 20596022
164. Allbritton J et al: Cronkhite-Canada syndrome: Report of two cases, biopsy findings in the associated alopecia, and a new treatment option. Cutis 61:229-232, 1998
165. Sethuraman G, Malhotra AK, Sharma VK: Alopecia universalis in Down syndrome: Response to therapy. Indian J Dermatol Venereol Leprol 72:454-455, 2006
166. Alkhalifah A et al: Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62:177-188, 2010
167. Alkhalifah A et al: Alopecia areata update: Part II. Treatment. J Am Acad Dermatol 62:191-202, 2010
168. Shapiro J Alopecia areata. Update on therapy. Dermatol Clin 11:35-46, 1993
169. Friedli A et al: Pulse
methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients.
J Am Acad Dermatol 39:597-602, 1998
170. Fiedler VC: Alopecia areata: Current therapy. J Invest Dermatol 96: 69S-70S, 1991
171. Whiting DA: The treatment of alopecia areata. Cutis 40:247-250, 1987
172. Price VH: Topical
minoxidil in extensive alopecia areata, including 3-year follow-up.
Dermatologica 175(Suppl. 2):36-41, 1987
173. Price VH: Double-blind, placebo-controlled evaluation of topical
minoxidil in extensive alopecia areata.
J Am Acad Dermatol 16:730-736, 1987
174. Morhenn VB et al: Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis. J Invest Dermatol 81:23-27, 1983
175. Fiedler-Weiss VC, Buys CM: Evaluation of
anthralin in the treatment of alopecia areata.
Arch Dermatol 123:1491-1493, 1987
176. Schmoeckel C et al: Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol 115:1254-1255, 1979
177. Happle R, Klein HM, Macher E: Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 278:214-218, 1986
178. MacDonald N, Wiseman MC, Shapiro J: Alopecia areata: Topical immunotherapy–Application and practical problems. J Cutan Med Surg 3(Suppl. 3): S36-S40, 1999
179. Shapiro J et al: Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone. J Investig Dermatol Symp Proc 4:239, 1999
180. Krook G: Treatment of alopecia areata with Kromayer's ultra-violet lamp. Acta Derm Venereol 41:178-181, 1961
181. Mitchell AJ, Douglass MC: Topical photochemotherapy for alopecia areata. J Am Acad Dermatol 12:644-649, 1985
182. Gupta AK et al: Oral
cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
J Am Acad Dermatol 22:242-250, 1990
183. Elmer KB, George RM: Congenital triangular alopecia: A case report and review. Cutis 4:255-256, 2002
184. Feuerman EJ: Congenital temporal triangular alopecia. Cutis 28(2):196-197, 1981
185. Kubba R, Rook A: Congenital triangular alopecia. Br J Dermatol 95(6):657-659, 1976
186. Bargman H: Congenital temporal triangular alopecia. Can Med Assoc 15;131(10):1253-1254, 1984
187. Kikuchi I, Okazaki M: Congenital temporal alopecia in phakomatosis pigmentovascularis. J Dermatol 9(6):485-487, 1982
188. Minars N: Congenital temporal alopecia. Arch Dermatol 109(3):395-396, 1974
189. Tosti A: Congenital triangular alopecia. J Am Acad Dermatol 16(5 pt 1):991-993, 1987
190. Trakimas C, Sperling LC, Skelton HG 3rd, Smith KJ, Buker JL: Clinical and histologic findings in temporal triangular alopecia. J Am Acad Dermatol 31(2 pt 1):205-209, 1994
191. Wu WY et al: Successful treatment of temporal triangular alopecia by hair restoration surgery using follicular unit transplantation. Dermatol Surg 35:1307-1310, 2009
192. Cuozzo DW et al: Essential syphilitic alopecia revisited. J Am Acad Dermatol 32:840-843, 1995
193. Olsen E SK et al: Update on cicatricial alopecia. J Investig Dermatol Symp Proc 8:18-19, 2003
194. Whiting DA: Cicatricial alopecia: Clinico-pathological findings and treatment. Clin Dermatol 19:211-215, 2001
195. Sellheyer K, Bergfeld WF: Histopathologic evaluation of alopecias. Am J Dermatopathol 28:236-259, 2006
196. Tan E MM, Ball N, Shapiro J: Primary cicatricial alopecias: Clinicopathology of 112 cases. J Am Acad Dermatol 50:25-32, 2004
197. Taylor G LM et al: Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102:451-461, 2000
198. Ross EK TE, Shapiro J: Update on primary cicatricial alopecias. J Am Acad Dermatol 53:1-37, 2005
199. Otberg N et al: Diagnosis and management of primary cicatricial alopecia: Part I. Skinmed 7:19-26, 2008
200. Wu WY et al: Diagnosis and management of primary cicatricial alopecia: Part II. Skinmed 7:78-83, 2008
201. Callen JP: Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol 118:412-416, 1982
202. Wilson CL et al: Scarring alopecia in discoid lupus erythematosus. Br J Dermatol 126:307-314, 1992
203. George PM, Tunnessen WW, Jr: Childhood discoid lupus erythematosus. Arch Dermatol 129:613-617, 1993
204. Moises-Alfaro C B-PR et al: Discoid lupus erythematosus in children: Clinical, histopathologic, and follow-up features in 27 cases. Pediatr Dermatol 20:103-107, 2003
205. Meyers DC WJ, Reddick RL: Verruciform xanthoma in association with discoid lupus erythematosus. J Cutan Pathol 19:156-158, 1992
206. Headington JT: Cicatricial alopecia. Dermatol Clin 14:773-782, 1996
207. Kossard S: Lymphocytic mediated alopecia: Histological classification by pattern analysis. Clin Dermatol 19:201-210, 2001
208. Solomon AR: The transversely sectioned scalp biopsy specimen: The technique and an algorithm for its use in the diagnosis of alopecia. Adv Dermatol 9:127-157, 1994
209. Templeton SF SA: Scarring alopecia: A classification based on microscopic criteria. J Cutan Pathol 21:97-109, 1994
210. Ruzicka T et al: Treatment of cutaneous lupus erythematosus with
acitretin and
hydroxychloroquine.
Br J Dermatol 127:513-518, 1992
211. Newton RC et al: Mechanism-oriented assessment of
isotretinoin in chronic or subacute cutaneous lupus erythematosus.
Arch Dermatol 122:170-176, 1986
212. Hamilton T et al: Successful hair re-growth with multimodal treatment of early cicatricial alopecia in discoid lupus erythematosus. Acta Derm Venereol 89:417-418, 2009
213. Eisen D: The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:431-436, 1999
214. Chieregato C et al: Lichen planopilaris: Report of 30 cases and review of the literature. Int J Dermatol 74:784-786, 2003
215. Phillips WG et al: Captopril-induced lichenoid eruption. Clin Exp Dermatol 19:17-20, 1994
216. Katta R: Lichen planus. Am Fam Physician 61:3319-3324, 27-28, 2000
217. Kang H et al: Lichen planopilaris. Dermatol Ther 21:249-56, 2008
218. Mehregan DA, Van Hale HM, Muller SA: Lichen planopilaris: Clinical and pathologic study of forty-five patients. J Am Acad Dermatol 27:935-942, 1992
219. Ott F BW, Geiger JM: Efficacy of oral low-dose
tretinoin (all-trans-retinoic acid) in lichen planus.
Dermatology 192:334-336, 1997
220. Mirmirani P WA, Price VH: Short course of oral
cyclosporine in lichen planopilaris.
J Am Acad Dermatol 49:667-671, 2003
221. Cribier B, Frances C, Chosidow O: Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol 134:1521-1530, 1998
222. Massa MC, Rogers RS, 3rd:
Griseofulvin therapy of lichen planus.
Acta Derm Venereol 61:547-550, 1981
223. Ronchese F: Pseudopelade. Arch Dermatol 82:336-343, 1960
224. Elston DM et al: Elastic tissue in scars and alopecia. J Cutan Pathol 27:147-152, 2000
225. Bulengo-Ransby SM, Headington JT: Pseudopelade of Brocq in a child. J Am Acad Dermatol 23:944-945, 1990
226. Alzolibani AA et al: Pseudopelade of Brocq. Dermatol Ther 21:257-263, 2008
227. Sperling LC, Sau P. The follicular degeneration syndrome in black patients. ‘Hot comb alopecia’ revisited and revised. Arch Dermatol 128:68-74, 1992
228. Callender VD, McMichael AJ, Cohen GF: Medical and surgical therapies for alopecias in black women. Dermatol Ther 17:164-176, 2004
229. Gibson LE MS, Peters MS: Follicular mucinosis of childhood and adolescence. Pediatr Dermatol 5:231-235, 1988
230. van Doorn R SE, Willemze R: Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: A clinicopathologic and follow-up study of 51 patients. Arch Dermatol 138:191-198, 2002
231. Boer A, Guo Y, Ackerman AB: Alopecia mucinosa is mycosis fungoides. Am J Dermatopathol 26(1):33-55, 2004
232. Emmerson RW: Follicular mucinosis. A study of 47 patients. Br J Dermatol 81:395, 1969
233. Baden HP BH: Clinical findings, cutaneous pathology, and response to therapy in 21 patients with keratosis pilaris atrophicans. Arch Dermatol 130:469-475, 1994
234. Powell JJ, Dawber RP GK: Folliculitis decalvans including tufted folliculitis: Clinical, histological and therapeutic findings. Br J Dermatol 140:328-333, 1999
235. Powell J DR: Successful treatment regime for folliculitis decalvans despite uncertainty of all aetiological factors. Br J Dermatol 144:428-429, 2001
236. Brooke RCC, Griffiths CEM: Folliculitis decalvans. Clin Exp Dermatol 26:20-22, 2001
237. Brozena SJ, Cohen LE, Fenske NA: Folliculitis decalvans: Response to
rifampin.
Cutis 42:512-515, 1988
238. Abeck D, Korting HC, Braun-Falco O: Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol 72:143-145, 1992
239. Sivakumaran S MP, Burrows NP. Dissecting folliculitis of the scalp with marginal keratitis. Clin Exp Dermatol 26:490-492, 2001
240. Ramasastry SS et al: Severe perifolliculitis capitis with osteomyelitis. Ann Plast Surg 18:241-244, 1987
241. Ongchi DR FM, Harris CA: Sternocostoclavicular hyperostosis: Two cases with differing dermatologic syndromes. J Rheumatol 17:1415-1418, 1990
242. Libow LF,Friar DA: Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: Treatment with
isotretinoin.
Cutis 64(2):87-99, 1999
243. Curry SS GD, King LEJ: Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol 4:673-678, 1981
244. Boyd AS, Zemtsov A: A case of pyoderma vegetans and the follicular occlusion triad. J Dermatol 19:61-63, 1992
245. Bergeron JR, Stone OJ: Follicular occlusion triad in a follicular blocking disease (pityriasis rubra pilaris). Dermatologica 136:362-367, 1968
246. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J 9:8, 2003
247. Goldsmith PC DP: Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and
minocycline.
J R Soc Med 86:729-730, 1993
248. Adrian RM AK: Perifolliculitis capitis: Successful control with alternate-day corticosteroids. Ann Plast Surg 4:166-169, 1980
249. Scerri L WH, Allen BR: Dissecting cellulitis of the scalp: Response to
isotretinoin.
Br J Dermatol 134:1105-1108, 1996
250. Koca R AH, Ozen OI, Tekin NS: Dissecting cellulitis in a white male: Response to
isotretinoin.
Int J Dermatol 41:509-513, 2002
251. Stites PC BA: Dissecting cellulitis in a white male: A case report and review of the literature. Cutis 67:37-40, 2001
252. Otberg N et al: Folliculitis decalvans. Dermatol Ther 21:238-244, 2008
253. Halder RM: Pseudofolliculitis barbae and related disorders. Dermatol Clin 6:407-412, 1988
254. Dinehart SM HA, Kerns BJ, Pollack SV: Acne keloidalis: A review. J Dermatol Surg Oncol 15:642-647, 1989
255. Stritzler C FR, Loveman AB: Acne necrotica; relation to acne necrotica miliaris and response to penicillin and other antibiotics. Arch Derm Syphilol 64:464-469, 1951
256. Kossard S CA, McCrossin I: Necrotizing lymphocytic folliculitis: The early lesion of acne necrotica (varioliformis). J Am Acad Dermatol 16:1007-1014, 1987
257. Maibach HI: Acne necroticans (varioliformis) versus Propionibacterium acnes folliculitis. J Am Acad Dermatol 21:323, 1989
258. Grattan CE PR, Boon A: Evidence for a role of local trauma in the pathogenesis of erosive pustular dermatosis of the scalp. Clin Exp Dermatol 13:7-10, 1988
259. Ena P LM, Doneddu GM, Campus GV: Erosive pustular dermatosis of the scalp in skin grafts: Report of three cases. Dermatology 194:80-84, 1997
260. Pye RJ PR, Burton JL: Erosive pustular dermatosis of the scalp. Br J Dermatol 100:559-566, 1979
261. Finner AM, Otberg N, Shapiro J: Secondary cicatricial and other permanent alopecias. Dermatol Ther 21:279-294, 2008
262. Rogers GEThe Biology of Wool and Hair, vol. 1, London, Chapman & Hall, 1989
263. Restrepo I et al: Two sisters, two different hair shaft abnormalities. Br J Dermatol 161:479-480, 2009
264. Tümer Z et al: Early copper-histidine treatment for Menkes disease. Nat Genet 12:11-13, 1996
265. Schweizer J: More than one gene involved in monilethrix: Intracellular but also extracellular players. J Invest Dermatol 126:1216, 2006
266. Zlotogorski A et al: An autosomal recessive form of monilethrix is caused by mutations in DSG4: Clinical overlap with localized autosomal recessive hypotrichosis. J Invest